Johnson & Johnson Letting Nonprofit Distribute Life-Saving Generic Tuberculosis Drug—Greatly Expanding Access In Poorer CountriesForbes • 07/13/23
Johnson & Johnson to Participate in the UBS MedTech, Tools and Genomics SummitBusiness Wire • 07/10/23
Johnson & Johnson 2Q financial results could beat even as pharma sales weighProactive Investors • 07/10/23
Nanobiotix surges on commercialization deal with J&J's Janssen for cancer therapeuticProactive Investors • 07/10/23
Nanobiotix ADRs Jump Over 50% After Agreement With J&J's Janssen PharmaceuticalInvestopedia • 07/10/23
Nanobiotix's stock soars after entering licensing, development deal with J&J's Janssen PharmaceuticaMarket Watch • 07/10/23
Johnson & Johnson: Supplemental BLA Of Carvykti Gives Great Growth OpportunitySeeking Alpha • 07/06/23
Seven Of The Top 10 Most-Valuable Stocks Are Still Cheap, Analysts SayInvestors Business Daily • 07/06/23